Drug Trial Radar · NCT01803360
Efficacy Study of Neridronate to Treat Painful Osteoarthritis of the Knee With Bone Marrow Lesions.
Last checked: Nov 19, 2026Latest source record: Mar 14, 2013 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Status unknown
Enrollment
60
Planned (sponsor's estimate)
Start
Mar 2013
Primary completion
Jul 2013
Study completion Sep 2013
Sponsor
- Lead sponsor
- ASST Gaetano Pini-CTOAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Mar 4, 2013
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to determine whether neridronate is effective in the treatment of pain related to bone marrow oedema in patients with osteoarthritis of the knee.
Conditions
- Osteoarthritis, Knee
Interventions
NeridronateDrug
Neridronate 100 mg solution for infusion: 4 intravenous administrations in a course of 10 days treatment
Primary outcomes
What the sponsor says the trial is designed to measure.
- knee pain reductionTime frame: 60 days
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Istituto Ortopedico Gaetano Pini
Milan, MI, Italy · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.